The DOI matches its Crossref record; 431 of the 431 references it cites were found in a registry or an index.
Inhibition and induction of CYP enzymes in humans: an update
Open accessAbstract
The cytochrome P450 (CYP) enzyme family is the most important enzyme system catalyzing the phase 1 metabolism of pharmaceuticals and other xenobiotics such as herbal remedies and toxic compounds in the environment. The inhibition and induction of CYPs are major mechanisms causing pharmacokinetic drug–drug interactions. This review presents a comprehensive update on the inhibitors and inducers of the specific CYP enzymes in humans. The focus is on the more recent human in vitro and in vivo findings since the publication of our previous review on this topic in 2008. In addition to the general presentation of inhibitory drugs and inducers of human CYP enzymes by drugs, herbal remedies, and toxic compounds, an in-depth view on tyrosine-kinase inhibitors and antiretroviral HIV medications as victims and perpetrators of drug–drug interactions is provided as examples of the current trends in the field. Also, a concise overview of the mechanisms of CYP induction is presented to aid the understanding of the induction phenomena.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–431 of 431
Mechanism of Inactivation of Human Cytochrome P450 2B6 by Phencyclidine
Jushchyshyn, M. I., Wahlstrom, J. L., Hollenberg, P. F., & Wienkers, L. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010579 · Cited by 22
Enantiomers of Warfarin and Phenobarbital
Orme, M. L., & Breckenridge, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197612232952613 · Cited by 22
Rolapitant Absolute Bioavailability and PET Imaging Studies in Healthy Adult Volunteers
Wang, X., Zhang, Z.-Y., Powers, D., Wang, J., Lu, S. M., & Kansra, V. V. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.637 · Cited by 22
Quantitative Prediction of CYP3A4‐ and CYP3A5‐Mediated Drug Interactions
Guo, Y., Lucksiri, A., Dickinson, G. L., Vuppalanchi, R., Hilligoss, J., & Hall, S. D. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1596 · Cited by 22
Rowland, A., van Dyk, M., Warncken, D., Mangoni, A. A., Sorich, M. J., & Rowland, A. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13478 · Cited by 21
Filppula, A. M., Mustonen, T. M., & Backman, J. T. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13088 · Cited by 21
Ford, N. P., Lee, Calmy, A., & Andrieux-Meyer (2012) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s20993 · Cited by 20
Belderbos, B. P. S., Bins, S., van Leeuwen, R. W. F., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2336 · Cited by 20
Carazo, A., Dusek, J., Holas, O., Škoda, J., Hyršová, L., Smutný, T., Soukup, T., Doseděl, M., & Pávek, P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00993 · Cited by 20
Indra, R., Pompach, P., Martínek, V., Takácsová, P., Vavrová, K., Heger, Z., Adam, V., Eckschlager, T., Kopečková, K., Arlt, V. M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143392 · Cited by 20
Li, A. C., Yu, E., Ring, S. C., & Chovan, J. P. (2013) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6758 · Cited by 19
Prieto-Castelló, M. J., Cardona, A., Marhuenda, D., Roel, J. M., & Corno, A. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.01.011 · Cited by 19
Carbamazepine but Not Valproate Induces CYP2A6 Activity in Smokers with Mental Illness
Williams, J. M., Gandhi, K. K., & Benowitz, N. L. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0384 · Cited by 19
Elsby, R., Hare, V., Neal, H., Outteridge, S. N., Pearson, C., Plant, K., Gill, R. U., Butler, P. J., & Riley, R. J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083832 · Cited by 19
Cada, D. J., Demaris, K., Levien, T. L., & Baker, D. E. (2013) · Hospital Pharmacy · doi:10.1310/hpj4803-231 · Cited by 19
The effect of phenobarbital on theophylline disposition in children with asthma
Saccar, C. L., Danish, M. A., Ragni, M. C., Rocci, M. L., Greene, J., Yaffe, S. J., & Mansmann, H. C. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(85)90099-5 · Cited by 18
Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro
Hu, X., Lan, T., Dai, D., Xu, R.-A., Yuan, L., Zhou, Q., Li, Y., Cai, J., & Hu, G. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071811 · Cited by 18
Kakuda, T. N., Solingen-Ristea, R. M. V., Onkelinx, J., Stevens, T., Aharchi, F., Smedt, G. D., Peeters, M., Leopold, L., & Hoetelmans, R. M. W. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.214 · Cited by 17
Luceri, F., Fattori, S., Luceri, C., Zorn, M., Mannaioni, P. F., & Messeri, G. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.198 · Cited by 17
Palacharla, V. R. C., Nirogi, R. V. S., Uthukam, V., Manoharan, A., Ponnamaneni, R. K., & Kalaikadhiban, I. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1354267 · Cited by 17
Iga, K. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.044 · Cited by 12
Chapron, B. D., Risler, L. J., Phillips, B., Collins, C. J., Thummel, K. E., & Shen, D. D. (2015) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3288c · Cited by 11
Metzger, I. F., Dave, N., Kreutz, Y., Lu, J. B. L., Galinsky, R. E., & Desta, Z. (2019) · Clinical and Translational Science · doi:10.1111/cts.12671 · Cited by 11
Impact of dioxins on antipyrine metabolism in firefighters
Chernyak, Y. I., Merinova, A. P., Шелепчиков, А. А., Kolesnikov, S. I., & Grassman, J. A. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.04.006 · Cited by 10
Yoshida, K. J., Maeda, K., Konagaya, A., & Kusuhara, H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081828 · Cited by 10
Role of raltegravir in the management of HIV-1 infection
Hicks, C. B., & Okeke (2011) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s13985 · Cited by 9
Wang, X., Zhang, Z., Arora, S., Wang, J., Lu, S. M., Powers, D., & Kansra, V. V. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1114 · Cited by 9
Significant drug–drug interaction between warfarin and nafcillin
King, C. A., Babcock, K. M., Godios, R. J., & King, B. S. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618796186 · Cited by 9
Samer, C. F., Gloor, Y. S., Rollason, V., Guessous, I., Doffey‐Lazeyras, F., Saurat, J. ‐., Sorg, O., Desmeules, J. A., & Daali, Y. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13339 · Cited by 9
Shebley, M., & Einolf, H. J. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1394 · Cited by 3
Interactions Between Conventional and Herbal Medicinal Products
Sevior, D. K., & Ahokas, J. T. (2017) · Springer eBooks · doi:10.1007/978-3-319-43806-1_5 · Cited by 2
Cited by
Cytochrome P450 Enzymes and Drug Metabolism in Humans
Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., He, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312808 · Cited by 1,070
Shyam Sunder, S., Sharma, U. C., & Pokharel, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01469-6 · Cited by 508
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tomuleasa, C., Tigu, A.-B., Munteanu, R., Moldovan, C.-S., Kegyes, D., Onaciu, A., Gulei, D., Ghiaur, G., Einsele, H., & Croce, C. M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01899-w · Cited by 260
Rani, J., Dhull, S. B., Rose, P. K., & Kidwai, M. K. (2024) · Phytomedicine · doi:10.1016/j.phymed.2023.155142 · Cited by 91
Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer
Barnett, B. S., & Greer, G. R. (2021) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2020.12.011 · Cited by 13
Metadata
- Authors
- Hakkola, J., Hukkanen, J., Turpeinen, M., & Pelkonen, O.
- Venue
- Archives of Toxicology
- Published
- 2020-10-27
- Volume
- 94
- Issue
- 11
- Pages
- 3671-3722
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W3095525985
- Cited by
- 418
- References
- 431
- FWCI
- 33.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.